The CTSA funding to the Michigan Institute for Clinical and Health Research (MICHR) in 2007 marked the beginning of a transformation of clinical-translational research (CTR) at the University of Michigan (UM). This award, coupled with strong institutional support and growing faculty engagement, enabled UM to evolve from a predominantly basic science research institution to one with a comprehensive research portfolio. This has been achieved on the foundation of: integrated and innovative training and educational programs that have touched nearly 2,000 trainees, faculty and staff;centralization and optimization of previously fragmented research services to create innovative opportunities for users;$10.2M distributed for pilot studies to accelerate innovation;and researcher participation in new partnerships with our communities and across the CTSA National Consortium. In the renewal period, CTSA funding leveraged with robust institutional support will enable MICHR to pursue 5 Overarching Objectives: 1) Optimize training and mentoring to create the next generation of research teams and clinical and translational investigators;2) Augment infrastructure and refine research services to reduce barriers and maximize research productivity across the entire translational research continuum;3) Foster collaborations and leverage innovative approaches and technologies to catalyze discovery;4) Enhance community- and practice-based partnerships to assure bi-directional learning, research, and implementation of findings to benefit health;5) Actively lead and contribute to national CTSA Consortium activities and engage in cross-CTSA collaborations. These will be achieved by: expanding education into new areas to strengthen the pipeline of CTR investigators and deploying more flexible training tools;strengthening existing services and launching new ones to impact study start-up times and recruitment;employing major informatics investments to fully integrate the needs of CTR investigators into IT landscape;utilizing new practice-based research networks;expanding evaluation to efficiently assess and optimize our performance. MICHR will be the engine of improvement and innovation in the conduct of high-quality, high impact-clinical and translational research to advance the health of Michigan and the nation.

Public Health Relevance

Translating scientific discoveries into real health gains is challenging. In recent decades this translation has been taking longer and costing more. The Michigan Institute for Clinical and Health Research provides infrastructure and services for researchers and increases access to research for the community. We help transform emerging knowledge into real changes in how we prevent and treat disease.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR000433-08S1
Application #
8902458
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Wilson, Todd
Project Start
2007-09-17
Project End
2017-05-31
Budget Start
2014-09-03
Budget End
2015-05-31
Support Year
8
Fiscal Year
2014
Total Cost
$1,897,763
Indirect Cost
$514,572
Name
University of Michigan Ann Arbor
Department
Pediatrics
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Schrauben, Sarah J; Hsu, Jesse Y; Rosas, Sylvia E et al. (2018) CKD Self-management: Phenotypes and Associations With Clinical Outcomes. Am J Kidney Dis 72:360-370
Miller, Nathaniel S; Chou, Kelvin L; Bohnen, Nicolaas I et al. (2018) Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease. Parkinsonism Relat Disord 48:54-60
Jenkins, Lisanne M; Skerrett, Kristy A; DelDonno, Sophie R et al. (2018) Individuals with more severe depression fail to sustain nucleus accumbens activity to preferred music over time. Psychiatry Res Neuroimaging 275:21-27
Slomine, Beth S; Silverstein, Faye S; Christensen, James R et al. (2018) Neurobehavioural outcomes in children after In-Hospital cardiac arrest. Resuscitation 124:80-89
Seekatz, Anna M; Bassis, Christine M; Fogg, Louis et al. (2018) Gut Microbiota and Clinical Features Distinguish Colonization With Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae at the Time of Admission to a Long-term Acute Care Hospital. Open Forum Infect Dis 5:ofy190
Fritz, Nora E; Boileau, Nicholas R; Stout, Julie C et al. (2018) Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease. J Neuropsychiatry Clin Neurosci 30:194-201
Hahn, Elizabeth A; Downing, Nancy R; Stout, Julie C et al. (2018) Understanding the need for assistance with survey completion in people with Huntington disease. Qual Life Res 27:801-810
Ryan, Benjamin J; Van Pelt, Douglas W; Guth, Lisa M et al. (2018) Plasma ferritin concentration is positively associated with in vivo fatty acid mobilization and insulin resistance in obese women. Exp Physiol 103:1443-1447
Hussain, Iram; Patni, Nivedita; Ueda, Masako et al. (2018) A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation. J Clin Endocrinol Metab 103:1005-1014
Shimasaki, Teppei; Seekatz, Anna; Bassis, Christine et al. (2018) Increased relative abundance of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae within the gut microbiota is associated with risk of bloodstream infection in long-term acute care hospital patients. Clin Infect Dis :

Showing the most recent 10 out of 776 publications